Clin Surg | Volume 6, Issue 1 | Research Article | Open Access

Bowel Resection during Surgery for Advanced Ovarian Carcinoma Oncological Outcomes

Maria Cuadra1, Jose Domingo Sardon2, Baltasar Cermeno2, Julene Argaluza3 and Inaki Lete1*

1Department of Obstetrics and Gynecology, Araba University Hospital, Spain
2Department of General Surgery, Araba University Hospital, Spain
3Department of Epidemiology and Public Health, Bioaraba Health Research Institute, Spain

*Correspondance to: Inaki Lete 

Fulltext PDF


Objective: To evaluate the short-term (morbidity associated with surgery) and long-term oncological outcomes results: Disease Free Survival (DFS) and Overall Survival (OS) of patients who underwent intestinal resection compared with those who did not undergo this technique during a surgery for advanced ovarian cancer. Methods: Retrospective study of patients undergoing surgery for stage IIB to IV ovarian cancer at our centre in the period from January 1st, 2010 to December 31st, 2019. Results: During the time period analyzed, we have treated 105 patients with stage IIB to IV ovarian cancer. In 71 patients (67.6%) the surgery did not include a bowel resection; while in 34 (32.4%) a resection was performed. Patients who underwent intestinal resection underwent longer surgeries, required more blood transfusions, more admissions to the Intensive Care Unit (ICU) and were admitted to the hospital for more days. The disease-free survival time was similar between both groups (41.8 months versus 32.2 months [p=0.91]) and the overall survival too (82.1 months vs. 50.4 months [p=0.66]). Conclusion: In the case of advanced stage ovarian carcinomas, bowel resection is associated with higher rates of morbidity and hospital stay but is not associated with lower DSF or OS.


Advanced ovarian neoplasms; Bowel resection; Disease free survival; Overall survival; Morbidity


Cuadra M, Sardon JD, Cermeno B, Argaluza J, Lete I. Bowel Resection during Surgery for Advanced Ovarian Carcinoma Oncological Outcomes. Clin Surg. 2021; 6: 3360..

Subscribe to Our Newsletter